<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Promising Clinical Results for Lupus Kidney Disease Treatment
Image Overlay - Promising Clinical Results for Lupus Kidney Disease Treatment

Promising Clinical Results for Lupus Kidney Disease Treatment

December 11, 2019

Promising Clinical Results for Lupus Kidney Disease Treatment

Aurinia Pharmaceuticals Inc. announced positive results for its phase III clinical trial for voclosporin, a treatment for active lupus nephritis, a life-threatening complication of lupus. The study met all of its primary and secondary endpoints, leading to complete remission in a signficant number of participants. Yourway is encouraged by this major breakthrough, the first therapy specifically approved for lupus-related kidney disease, and the tremendous benefits it will have for this patient population.

 Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Clinical Trial Supply New England

April 14-15, 2026
Boston, MA

GCSG 2026 US Conference

April 27-29, 2026
San Diego, CA

Media

Articles

White-Glove by Design: The Yourway Standard in Clinical Logistics

Open chat
Come chat with us!
Hello! How can I help you?